Back to User profile » Dr Kalliopi Pazaitou-Panayiotou
Paper published by Dr Kalliopi Pazaitou-Panayiotou:
Original Research
Treatment compliance and severe adverse events limit the use of tyrosine kinase inhibitors in refractory thyroid cancer
Chrisoulidou A, Mandanas S, Margaritidou E, Mathiopoulou L, Boudina M, Georgopoulos K, Pazaitou-Panayiotou K
OncoTargets and Therapy 2015, 8:2435-2442
Published Date: 3 September 2015